✦ LIBER ✦

Sorafenib for recurrence of hepatocellular carcinoma after liver transplantation

✍ Scribed by Arndt Weinmann; Ina Maria Niederle; Sandra Koch; Maria Hoppe-Lotichius; Michael Heise; Christoph Düber; Marcus Schuchmann; Gerd Otto; Peter Robert Galle; Marcus-Alexander Wörns

Book ID: 119230053
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 237 KB
Volume: 44
Category: Article
ISSN: 1590-8658
DOI: 10.1016/j.dld.2011.12.009

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and Safety of Combination Thera

Efficacy and Safety of Combination Therapy With Everolimus and Sorafenib for Recurrence of Hepatocellular Carcinoma After Liver Transplantation

✍ De Simone, P.; Crocetti, L.; Pezzati, D.; Bargellini, I.; Ghinolfi, D.; Carrai, 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 210 KB

High toxicity of sorafenib for recurrent

High toxicity of sorafenib for recurrent hepatocellular carcinoma after liver transplantation

✍ Katharina Staufer; Lutz Fischer; Barbara Seegers; Eik Vettorazzi; Bjoern Nashan; 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 99 KB

Sorafenib for the Treatment of Recurrent

Sorafenib for the Treatment of Recurrent Hepatocellular Carcinoma After Liver Transplantation?

✍ Vitale, A.; Boccagni, P.; Kertusha, X.; Zanus, G.; D'Amico, F.; Lodo, E.; Pastor 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 164 KB

Safe use of sorafenib in a patient under

Safe use of sorafenib in a patient undergoing salvage liver transplantation for recurrent hepatocellular carcinoma after hepatic resection

✍ Richard Kim; Narayanan Menon; Federico Aucejo 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 260 KB

Efficacy and safety of sorafenib in comb

Efficacy and safety of sorafenib in combination with mammalian target of rapamycin inhibitors for recurrent hepatocellular carcinoma after liver transplantation

✍ Carlos Gomez-Martin; Javier Bustamante; Javier F. Castroagudin; Magdalena Salced 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 185 KB 👁 1 views

There is currently no consensus on the most suitable treatment for the recurrence of hepatocellular carcinoma (HCC) after liver transplantation. This open, multicenter, retrospective, uncontrolled cohort study was designed to evaluate the safety and preliminary efficacy of the combined use of a mamm

Sorafenib Treatment for Recurrent Hepato

Sorafenib Treatment for Recurrent Hepatocellular Carcinoma After Liver Transplantation

✍ Sotiropoulos, G.C.; Nowak, K.W.; Fouzas, I.; Vernadakis, S.; Kykalos, S.; Klein, 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 100 KB